Rosenblatt Boosts IMAX Target to $65, Signaling Short-Term Upside
Sep 9, 2026, 9:25 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
A higher target and Buy rating from a named analyst (Rosenblatt) can attract buyers, especially given IMAX's recent price around $52.66. Historically, such upgrades can spark 5–15% intraday moves and 1–3 week follow-through if corroborated by other firms.
AI summary
What happened, with direct paths to the underlying reporting
Rosenblatt Securities raised IMAX's price target to $65 from $60 while keeping a Buy rating, signaling renewed optimism about the cinema exhibitor's near-term upside. With IMAX stock trading around $52.66, the upgrade could attract momentum buyers and push shares toward the new target if the market maintains positive sentiment and follows with additional upgrades.
Rosenblatt lifts IMAX price target to $65 from $60. Buy rating maintained.
IMAX closed at $52.66 on Tuesday; near-term upside implied.
Analyst upgrades may attract traders; watch for further revisions.
Target suggests ~23% upside potential from current levels.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event